{"id":"https://openalex.org/W2787916670","doi":null,"title":"\"An International Randomized Placebo-Controlled Trial of a Four-Component Combination Pill (\"Polypill\") in People with Raised Cardiovascular Risk\"","display_name":"\"An International Randomized Placebo-Controlled Trial of a Four-Component Combination Pill (\"Polypill\") in People with Raised Cardiovascular Risk\"","alternate_titles":[],"publication_year":2011,"publication_date":"2011-11-01","ids":{"openalex":"https://openalex.org/W2787916670","mag":"2787916670"},"language":"en","primary_location":{"id":"mag:2787916670","doi":null,"is_oa":false,"landing_page_url":"https://www.sid.ir/en/VEWSSID/J_pdf/86920110613.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S112058147","display_name":"Archives of Iranian Medicine","issn_l":"1029-2977","issn":["1029-2977","1735-3947"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4327874770","host_organization_name":"Academy of Medical Sciences, I.R. Iran","host_organization_lineage":["https://openalex.org/P4327874770"],"host_organization_lineage_names":["Academy of Medical Sciences, I.R. Iran"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Archives of Iranian Medicine","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2787916670"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065878670","display_name":"Behrouz Navabakhsh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Behrouz Navabakhsh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014214187","display_name":"Reza Malekzadeh","orcid":"https://orcid.org/0000-0002-9820-6335","observed_orcids":["https://orcid.org/0000-0002-9820-6335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reza Malekzadeh","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1043-3814","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2146,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.60567682,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"14","issue":"6","first_page":"433","last_page":"435"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.03689999878406525,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14212","display_name":"Health Promotion and Cardiovascular Prevention","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polypill","display_name":"polypill","score":0.9860000014305115},{"id":"https://openalex.org/keywords/combination-antihypertensive-therapy","display_name":"combination antihypertensive therapy","score":0.8550000190734863},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.796999990940094},{"id":"https://openalex.org/keywords/lisinopril","display_name":"lisinopril","score":0.996999979019165},{"id":"https://openalex.org/keywords/hydrochlorothiazide","display_name":"hydrochlorothiazide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.5709999799728394},{"id":"https://openalex.org/keywords/systolic-blood-pressure-reduction","display_name":"systolic blood pressure reduction","score":0.8679999709129333},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.7900000214576721},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7630000114440918},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cardiovascular-disease-prevention","display_name":"cardiovascular disease prevention","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C2777758740","wikidata":"https://www.wikidata.org/wiki/Q2103071","display_name":"Polypill","level":3,"score":0.9656330347061157},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8923484086990356},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8434628248214722},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6935694217681885},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6642651557922363},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.5583067536354065},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5479639768600464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5204975008964539},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.5195786952972412},{"id":"https://openalex.org/C81603835","wikidata":"https://www.wikidata.org/wiki/Q3457430","display_name":"Pill","level":2,"score":0.4718703627586365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32450544834136963},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2720375955104828},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2787916670","doi":null,"is_oa":false,"landing_page_url":"https://www.sid.ir/en/VEWSSID/J_pdf/86920110613.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S112058147","display_name":"Archives of Iranian Medicine","issn_l":"1029-2977","issn":["1029-2977","1735-3947"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4327874770","host_organization_name":"Academy of Medical Sciences, I.R. Iran","host_organization_lineage":["https://openalex.org/P4327874770"],"host_organization_lineage_names":["Academy of Medical Sciences, I.R. Iran"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Archives of Iranian Medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1480738579","https://openalex.org/W1544587904","https://openalex.org/W1975797691","https://openalex.org/W2004524291","https://openalex.org/W2040885081","https://openalex.org/W2074644304","https://openalex.org/W2083377545","https://openalex.org/W2100155691","https://openalex.org/W2110171695","https://openalex.org/W2120335639","https://openalex.org/W2123832862","https://openalex.org/W2144553637","https://openalex.org/W2147619026","https://openalex.org/W2160547085","https://openalex.org/W2162349196","https://openalex.org/W2163207768","https://openalex.org/W2403302473"],"related_works":["https://openalex.org/W1733314917","https://openalex.org/W1480738579","https://openalex.org/W3101533148","https://openalex.org/W2032147022","https://openalex.org/W7124733641","https://openalex.org/W2041233529","https://openalex.org/W2188950424","https://openalex.org/W2072788163","https://openalex.org/W2232929225"],"abstract_inverted_index":{"Summary:":[0],"There":[1],"is":[2,230],"widespread":[3],"interest":[4],"in":[5,68,152,209,218,221,226],"the":[6,78,153,179],"potential":[7],"for":[8,74,257],"com-":[9],"bination":[10],"cardiovascular":[11,28,228],"medications":[12],"consisting":[13],"of":[14,51,77,174,201,241],"aspirin":[15],"and":[16,23,42,64,97,116,137,194,211],"other":[17],"agents":[18],"to":[19,26,134,145,157,168,178],"lower":[20,232],"blood":[21,93,111],"pressure":[22,94,112],"cholesterol":[24,139],"(polypills)":[25],"reduce":[27],"diseases":[29],"(CVDs).":[30],"However,":[31],"no":[32,72],"reliable":[33],"placebo-":[34],"controlled":[35],"data":[36],"are":[37],"available":[38],"on":[39],"both":[40],"efcacy":[41],"tolerability.":[43],"We":[44],"conducted":[45],"a":[46,52,191,237],"randomized,":[47],"double-blind":[48],"placebo-controlled":[49],"trial":[50,202],"polypill":[53,124,154,205],"(aspirin":[54],"75":[55],"mg,":[56,59],"lisinopril":[57],"10":[58],"hydrochloro-":[60],"thiazide":[61],"12.5":[62],"mg":[63],"simvastatin":[65],"20":[66],"mg)":[67],"378":[69],"individuals":[70],"with":[71,236],"indications":[73],"any":[75],"component":[76,180],"polypill,":[79],"whose":[80],"estimated":[81],"\ufffdve-year":[82],"CVD":[83],"risks":[84],"were":[85,91,159],"over":[86],"7.5%.":[87],"The":[88,148,224],"primary":[89],"outcomes":[90],"systolic":[92],"(SBP),":[95],"LDL-cholesterol":[96,118],"tolerability":[98],"(proportion":[99],"discontinued":[100],"randomized":[101],"therapy)":[102],"at":[103,254],"12":[104,122],"weeks":[105,193],"follow-":[106],"up.":[107],"At":[108],"baseline,":[109],"mean":[110,117],"was":[113,119,171,187],"134/81":[114],"mmHg":[115,136],"3.7mmol/L.":[120],"Over":[121],"weeks,":[123],"treat-":[125],"ment":[126],"reduced":[127],"SBP":[128,210],"by":[129,140],"9.9":[130],"(95%":[131,142],"CI:":[132,143,166],"7.7":[133],"12.1)":[135],"LDL-":[138],"0.8":[141],"0.6":[144],"0.9)":[146],"mmol/L.":[147],"discontinua-":[149],"tion":[150],"rates":[151],"group":[155],"compared":[156],"placebo":[158],"23%":[160],"vs.":[161,183],"18%":[162],"(RR":[163],"1.33,":[164],"95%":[165],"0.89":[167],"2.00,":[169],"P=0.2).There":[170],"an":[172],"excess":[173],"side":[175,216,242],"effects":[176,217],"known":[177],"medicines":[181],"(58%":[182],"42%,":[184],"P=0.001),":[185],"which":[186],"mostly":[188],"apparent":[189],"within":[190],"few":[192],"usu-":[195],"ally":[196],"did":[197],"not":[198],"warrant":[199],"cessation":[200],"treatment.":[203],"This":[204],"achieved":[206],"sizeable":[207],"reductions":[208],"LDL-cho-":[212],"lesterol":[213],"but":[214],"caused":[215],"about":[219],"1":[220],"6":[222],"people.":[223],"halving":[225],"predicted":[227],"risk":[229,256],"moderately":[231,238],"than":[233],"previous":[234],"estimates,":[235],"higher":[239],"rate":[240],"effects.":[243],"Nonethe-":[244],"less,":[245],"substantial":[246],"net":[247],"benets":[248],"would":[249],"be":[250],"expected":[251],"among":[252],"patients":[253],"high":[255],"CVDs.":[258]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2787916670","counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2018-03-06T00:00:00"}
